Insiders CURE BIOT OTC Markets

Equities

CUBT

US23128N2071

Delayed OTC Markets Other stock markets 03:45:51 2024-06-06 pm EDT			5-day change	1st Jan Change
0.0182 ^USD	-4.21%		-5.21%	-14.55%

May. 06	Curative Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million.	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Curative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors	22-06-16	CI
Curative Biotechnology, Inc. Appoints Cary Sucoff to Board of Directors	22-05-12	CI
Curative Biotechnology, Inc. Appoints Dr. Catherine Sohn as Special Advisor to Board and CEO	21-10-12	CI
Curative Biotechnology, Inc. Announces Addition of Dr. Nicholas Boulis to Scientific and Clinical Advisory Board	21-09-02	CI
Curative Biotechnology, Inc. Announces Additions to Scientific and Clinical Advisory Board	21-04-29	CI
Connectyx Technologies Holdings Group, Inc. Announces Management Changes	21-02-11	CI
Connectyx Technologies Holdings Group, Inc. Appoints I Richard Garr as Chief Executive Officer	21-02-11	CI
Connectyx Announces Appointment of Michael K. Fish to Board of Directors	20-11-24	CI
Connectyx Appoints I. Richard Garr, Esq. to Company’S Scientific Advisory Board	20-05-19	CI
Connectyx Technologies Holdings Group, Inc. Announces Board Changes	20-05-08	CI
Connectyx Technologies Holdings Group Announces Management Changes	20-03-06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer